Listar por tema "hydroxymethylglutaryl coenzyme A reductase inhibitor"

Mostrando ítems 1-3 de 3

A 'Polypill' aimed at preventing cardiovascular disease could prove highly cost-effective for use in Latin America

Bautista, Leonelo E.; Vera-Cala, Lina M.; Ferrante, Daniel; Herrera, Victor M.; Miranda, J. Jaime; Pichardo, Rafael; Sánchez Abanto, Jorge R.; Ferreccio, Catterina; Silva, Eglé; Arenas, Myriam O.; Chirinos, Julio A.; Medina-Lezama, Josefina; Pérez, Cynthia M.; Schapochnik, Norberto; Casas, Juan P. (Project HOPE, 2013)

We evaluated the cost-effectiveness of administering a daily “polypill” consisting of three antihypertensive drugs, a statin, and aspirin to prevent cardiovascular disease among high-risk patients in Latin America. We found ...
Registry of people with diabetes in three Latin American countries: A suitable approach to evaluate the quality of health care provided to people with type 2 diabetes

Commendatore, V.; Dieuzeide, G.; Faingold, C.; Fuente, G.; Luján, D.; Aschner, P.; Lapertosa, S.; Villena Chavez, Jaime Eduardo; Elgart, J.; Gagliardino, J.J. (Wiley, 2013)

Aims: To implement a patient registry and collect data related to the care provided to people with type 2 diabetes in six specialized centers of three Latin American countries, measure the quality of such care using a ...
SGLT-2 inhibitors for people with type 2 diabetes.

Málaga Rodríguez, Germán Javier; Ruiz, Eloy F. (Elsevier, 2019)

Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials showing reductions in cardiovascular death, myocardial infarction, and stroke—would suggest they have much to ...

Listar por tema "hydroxymethylglutaryl coenzyme A reductase inhibitor"

Listar por tema "hydroxymethylglutaryl coenzyme A reductase inhibitor"

Buscar en el Repositorio

Listar

Todo el Repositorio

Panel de Control